An innovative new treatment option for bladder cancer, recently approved by the U.S. Food and Drug Administration, has been performed for the first time in Maryland.

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

The Food and Drug Administration has approved a new treatment for patients with bladder cancer that does not respond well to standard therapy. The treatment, which will be sold under the brand name ...

Urogynecology is a specialized field of gynecology and obstetrics that deals with female pelvic medicine and reconstructive surgery. Urogynecologists are doctors who diagnose and treat pelvic floor ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

You've been diagnosed with bladder cancer that has not invaded the muscle layer -- i.e., non-muscle invasive bladder cancer (NMIBC), also called superficial bladder cancer. Although the cure rate with ...

Millennium Health & Wellness, led by world-renowned Dr. Brian Hesser, has introduced Emsella to its growing suite of ...

Struggling with frequent bathroom trips or a weak urine stream? Learn how to manage BPH with personalized care, from ...

The National Institute for Health and Care Excellence (NICE) published draft guidance recommending avelumab (Bavencio, Merck Serono) for the treatment of certain forms of bladder cancer. Adults with ...